Biblio Discovery — Demo Discovery Service

38 results for "Li-jun Yan"

Showing 21–38 · 9.69 seconds · RSS

  1. Journal Article Full text

    ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin‐3 and NRXN3

    Zhao, Yin; Hong, Xiao‐Hong; Li, Kang et al.

    Cancer Commun (Lond) · 2020 · English · PubMed Central

    BACKGROUND: Epigenetic regulation plays an important role in the development and progression of nasopharyngeal carcinoma (NPC). However, the epigenetic mechanisms underlying NPC metastasis remains poorly understood. We aimed to find functional genes which regulate the metastasis of NPC and identify…

  2. Journal Article Full text

    Spatial heterogeneity of immune infiltration predicts the prognosis of nasopharyngeal carcinoma patients

    Wang, Ya-Qin; Liu, Xu; Xu, Cheng et al.

    Oncoimmunology · 2021 · English · PubMed Central

    Spatial information on the tumor immune microenvironment is of clinical relevance. Here, we aimed to quantify the spatial heterogeneity of lymphocytes and cancer cells and evaluated its prognostic value in patients with nasopharyngeal carcinoma (NPC). The scanned immunohistochemistry images of 336…

  3. Journal Article Full text

    LC3-dependent intercellular transfer of phosphorylated STAT1/2 elicits CXCL9(+) macrophages and enhances radiation-induced antitumor immunity

    Li, Jun-Yan; Li, Ying-Qing; Dai, Jia-Hao et al.

    J Clin Invest · 2025 · English · PubMed Central

    The efficacy of anticancer treatments, including radiotherapy, depends on the activation of type I IFN signaling. However, its regulatory networks and mechanisms remain to be elucidated. Here, we report that tumor cell–intrinsic type I IFN signaling can be transferred to macrophages via secretory…

  4. Journal Article Full text

    Development and validation of an immune checkpoint-based signature to predict prognosis in nasopharyngeal carcinoma using computational pathology analysis

    Wang, Ya-Qin; Zhang, Yu; Jiang, Wei et al.

    J Immunother Cancer · 2019 · English · PubMed Central

    BACKGROUND: Immunotherapy, especially immune checkpoint inhibition, has provided powerful tools against cancer. We aimed to detect the expression of common immune checkpoints and evaluate their prognostic values in nasopharyngeal carcinoma (NPC). METHODS: The expression of 9 immune checkpoints…

  5. Journal Article Full text

    Hypermethylation of UCHL1 Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN)

    Zhao, Yin; Lei, Yuan; He, Shi-Wei et al.

    Cells · 2020 · English · PubMed Central

    Epigenetic regulation plays an important role in the development and progression of nasopharyngeal carcinoma (NPC), but the epigenetic mechanisms underlying NPC metastasis remain poorly understood. Here, we demonstrate that hypermethylation of the UCHL1 promoter leads to its downregulation in NPC…

  6. Journal Article Full text

    Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinoma

    Fang, Xue-Liang; Li, Qing-Jie; Lin, Jia-Yi et al.

    Cell Death Dis · 2024 · English · PubMed Central

    Despite that the docectaxel-cisplatin-5-fluorouracil (TPF) induction chemotherapy has greatly improved patients’ survival and became the first-line treatment for advanced nasopharyngeal carcinoma (NPC), not all patients could benefit from this therapy. The mechanism underlying the TPF…

  7. Journal Article Full text

    PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma

    Huang, Sheng-Yan; Gong, Sha; Zhao, Yin et al.

    Nat Commun · 2024 · English · PubMed Central

    Chemoresistance is a main reason for treatment failure in patients with nasopharyngeal carcinoma, but the exact regulatory mechanism underlying chemoresistance in nasopharyngeal carcinoma remains to be elucidated. Here, we identify PJA1 as a key E3 ubiquitin ligase involved in nasopharyngeal…

  8. Journal Article Full text

    T cell-redirecting antibody for treatment of solid tumors via targeting mesothelin

    Liu, Jun-jun; Pan, Zhi-di; Yue, Ya-li et al.

    Acta Pharmacol Sin · 2024 · English · PubMed Central

    T cell engaging bispecific antibodies (TCBs) have recently become significant in cancer treatment. In this study we developed MSLN490, a novel TCB designed to target mesothelin (MSLN), a glycosylphosphatidylinositol (GPI)-linked glycoprotein highly expressed in various cancers, and evaluated its…

  9. Journal Article Full text

    Fusobacterium nucleatum manipulates host autophagy to promote its intracellular survival and treatment resistance in nasopharyngeal carcinoma

    Wang, Jing-Yun; Lu, Ying-Qi; Tan, Xi-Rong et al.

    Mol Cancer · 2026 · English · PubMed Central

    BACKGROUND: Growing evidence highlights the existence and tumor-promoting role of intratumoral bacteria in various types of cancers. However, the mechanisms enabling the intracellular survival of these microorganisms remain poorly understood, impeding the development of microbiota-targeting…

  10. Journal Article Full text

    Circulating Microbial Metabolites Predict Tumor Relapse and Chemotherapy Efficacy in Nasopharyngeal Carcinoma

    Li, Jun‐Yan; Yao, Yao; Tan, Xi‐Rong et al.

    MedComm (2020) · 2026 · English · PubMed Central

    The value of microbial metabolites in prognosis and treatment response prediction in patients with nasopharyngeal carcinoma (NPC) remains unclear. Here, through the untargeted metabolomic analysis of plasma in 48 paired NPC patients with or without tumor relapse, we identified distinct circulating…

  11. Journal Article Full text

    TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models

    Li, Jun-Yan; Zhao, Yin; Gong, Sha et al.

    Nat Commun · 2023 · English · PubMed Central

    Although radiotherapy can promote antitumour immunity, the mechanisms underlying this phenomenon remain unclear. Here, we demonstrate that the expression of the E3 ubiquitin ligase, tumour cell-intrinsic tripartite motif-containing 21 (TRIM21) in tumours, is inversely associated with the response…

  12. Journal Article Full text

    Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China

    Qiao, Han; Tan, Xi-Rong; Li, Hui et al.

    JAMA Oncol · 2022 · English · PubMed Central

    IMPORTANCE: Microbiota-tumor interactions have qualified microbiota as a promising prognostic biomarker in various types of cancers. Although the nasopharynx acts as a crucial niche of the upper respiratory tract microbiome, whether the intratumoral microbiota exists and its clinical significance…

  13. Journal Article Full text

    A lncRNA signature associated with tumor immune heterogeneity predicts distant metastasis in locoregionally advanced nasopharyngeal carcinoma

    Liang, Ye-Lin; Zhang, Yuan; Tan, Xi-Rong et al.

    Nat Commun · 2022 · English · PubMed Central

    Increasing evidence has revealed the roles of long noncoding RNAs (lncRNAs) as tumor biomarkers. Here, we introduce an immune-associated nine-lncRNA signature for predicting distant metastasis in locoregionally advanced nasopharyngeal carcinoma (LA-NPC). The nine lncRNAs are identified through…

  14. Journal Article Full text

    Tissue-resident microbiota signature in nasopharyngeal carcinoma

    Tan, Xi-Rong; Qiao, Han; Li, Ying-Qing et al.

    Microbiome · 2025 · English · PubMed Central

    BACKGROUND: Emerging evidence reveals that microbiota plays a crucial role in multiple cancers. Nasopharyngeal carcinoma (NPC) tissues harbour microbiota, highlighting the need to investigate the clinical implications of tissue-resident microbiota in the development of NPC. Here, we aim to clarify…

  15. Journal Article Full text

    Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses

    Chen, Yu-Pei; Lv, Jia-Wei; Mao, Yan-Ping et al.

    Mol Cancer · 2021 · English · PubMed Central

    Currently, there is no strong evidence of the well-established biomarkers for immune checkpoint inhibitors (ICIs) in nasopharyngeal carcinoma (NPC). Here, we aimed to reveal the heterogeneity of tumour microenvironment (TME) through virtual microdissection of gene expression profiles. An…

  16. Journal Article Full text

    A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

    Lei, Yuan; Li, Ying-Qin; Jiang, Wei et al.

    J Natl Cancer Inst · 2020 · English · PubMed Central

    BACKGROUND: Induction chemotherapy (IC) followed by concurrent chemoradiotherapy is the mainstay treatment for patients with locoregionally advanced nasopharyngeal carcinoma. However, some patients obtain little benefit and experience unnecessary toxicities from IC. We intended to develop a…

  17. Journal Article Full text

    Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma

    Chen, Yu-Pei; Yin, Jian-Hua; Li, Wen-Fei et al.

    Cell Res · 2020 · English · PubMed Central

    Nasopharyngeal carcinoma (NPC) is an aggressive malignancy with extremely skewed ethnic and geographic distributions. Increasing evidence indicates that targeting the tumor microenvironment (TME) represents a promising therapeutic approach in NPC, highlighting an urgent need to deepen the…